Nurse Practitioner, Family · Marshall, MO
NPI
1881132587
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1547 Commerce Dr
Marshall, MO, 65340
Phone (660) 831-3092
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$890K
12,131 prescriptions
Company payments, 2025
$1,234
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Dana Zinn prescribed most often to Medicare patients was Atorvastatin Calcium, with 673 prescriptions and refills. In total Dana Zinn wrote 12,131 Medicare prescriptions that cost $890K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 673 | 727 | 63 | $9,411 |
| Omeprazole Generic | 668 | 714 | 66 | $8,451 |
| Levothyroxine Sodium Generic | 621 | 649 | 53 | $8,534 |
| Fluticasone Propionate Generic | 453 | 506 | 67 | $11K |
| Metformin Hcl Generic | 344 | 374 | 34 | $3,441 |
| Pantoprazole Sodium Generic | 323 | 338 | 33 | $6,616 |
| Amlodipine Besylate Generic | 313 | 340 | 31 | $2,342 |
| Lisinopril Generic | 303 | 354 | 34 | $2,503 |
| Montelukast Sodium Generic | 258 | 260 | 21 | $3,896 |
| Tamsulosin Hcl Generic | 225 | 248 | 22 | $3,817 |
| Gabapentin Generic | 172 | 189 | 18 | $3,742 |
| Propranolol Hcl Generic | 163 | 166 | 15 | $3,568 |
| Furosemide Generic | 162 | 167 | 16 | $965 |
| Famotidine Generic | 151 | 152 | 23 | $2,074 |
| Potassium Chloride Generic | 132 | 143 | 14 | $2,258 |
Brand drugs: 1,007 claims; generic drugs: 10,891 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dana Zinn $1,234 ($1,234 in general payments such as food, travel and fees) from 11 companies. The largest payer was Vanda Pharmaceuticals Inc. with $283.
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | 12 | $283 |
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $197 |
| Janssen Pharmaceuticals, Inc JNJ | 8 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 8 | $139 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $139 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $118 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $102 |
| Axsome Therapeutics, Inc. AXSM | 2 | $39.85 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $32.89 |
| Exact Sciences Corporation EXAS | 1 | $21.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.